Transfusion Reactions and Complications

Transfusion reactions and complications are the adverse events that follow the transfusion of blood or blood components, ranging from common, self-limited febrile and allergic reactions to rare but life-threatening events such as acute hemolysis from ABO-incompatible blood, transfusion-related acute lung injury, and circulatory overload. As a hematopathology area, this topic organizes how these events are recognized, classified by mechanism and timing, investigated in the laboratory, and counted by hemovigilance systems.

Definition

A transfusion reaction is an adverse event temporally associated with the transfusion of a blood component, conventionally classified by timing (acute, occurring within about 24 hours, versus delayed) and by mechanism (immune-mediated versus non-immune).

Scope

This area provides an orienting overview of immune-mediated and non-immune adverse effects of transfusion and links to the detailed topic entries beneath it: acute and delayed hemolytic reactions, febrile and allergic/anaphylactic reactions, the pulmonary and circulatory complications TRALI and TACO, and the hemovigilance systems that monitor them. It treats transfusion reactions as a reference and classification subject within laboratory hematology, not as bedside clinical guidance.

Sub-topics

• Acute Hemolytic Transfusion Reaction (ABO Incompatibility and Acute Serologic Incompatibility)
• Delayed Hemolytic Transfusion Reaction (Alloantibody-Mediated)
• Febrile Non-Hemolytic and Allergic/Anaphylactic Transfusion Reactions
• Hemovigilance Systems and Post-Transfusion Complication Surveillance
• Transfusion-Related Acute Lung Injury (TRALI) and Transfusion-Associated Circulatory Overload (TACO)

Key concepts

• Acute versus delayed reactions
• Immune-mediated versus non-immune mechanisms
• ABO incompatibility and intravascular hemolysis
• Alloimmunization to red cell antigens
• Febrile non-hemolytic reactions
• Allergic and anaphylactic reactions
• Transfusion-related acute lung injury (TRALI)
• Transfusion-associated circulatory overload (TACO)
• Hemovigilance and adverse event surveillance

Mechanisms

Transfusion reactions arise through several distinct pathways. Immune-mediated hemolysis follows binding of recipient antibodies to donor red cell antigens, classically the ABO mismatch that triggers complement-mediated intravascular destruction. Pre-formed or anamnestic alloantibodies to other red cell antigens produce delayed, mostly extravascular hemolysis. Febrile non-hemolytic reactions are attributed to recipient antibodies against donor leukocytes and to cytokines accumulated in stored components, while allergic reactions reflect hypersensitivity to plasma proteins, with anaphylaxis in IgA-deficient recipients with anti-IgA. Pulmonary injury (TRALI) and circulatory overload (TACO) are the leading causes of transfusion-related mortality in contemporary series. Delaney and colleagues review this mechanistic framework, and Vamvakas and Blajchman summarize the shift in the dominant causes of transfusion-related death.

Clinical relevance

Understanding the categories of transfusion reactions underpins laboratory investigation of suspected reactions and the interpretation of hemovigilance data. This area describes how adverse events are classified and studied; it is a reference resource and does not provide diagnostic thresholds, dosing, or individualized management recommendations.

Epidemiology

Mild febrile and allergic reactions are the most frequently reported events, while serious complications are uncommon. National hemovigilance programs such as the UK Serious Hazards of Transfusion (SHOT) scheme have documented that, after the near-elimination of many infectious risks, the major hazards are now non-infectious — including TRALI, TACO, and errors leading to incorrect-blood-component transfusion. Bolton-Maggs and Cohen describe these surveillance findings and the resulting safety improvements.

History

Adverse reactions were recognized from the earliest era of human transfusion, but systematic understanding followed the discovery of the ABO and Rh blood group systems and the development of compatibility testing. Over the twentieth century, infectious hazards dominated attention; with improved donor screening and testing, the focus shifted to immune and non-immune complications. The establishment of organized hemovigilance networks in the 1990s, such as SHOT in the United Kingdom, made systematic measurement of these complications possible.

Seminal works

• delaney-2016
• vamvakas-blajchman-2009
• bolton-maggs-2013

Frequently asked questions

How are transfusion reactions classified?

They are conventionally grouped by timing (acute, within about 24 hours, versus delayed) and by mechanism (immune-mediated, such as hemolytic, febrile, and allergic reactions, versus non-immune, such as circulatory overload).

What are the most serious transfusion complications today?

Hemovigilance data identify transfusion-related acute lung injury (TRALI), transfusion-associated circulatory overload (TACO), and acute hemolysis from ABO-incompatible blood among the leading causes of transfusion-related mortality.